Gastrointestinal Cancer section

Gastrointestinal Cancer News & Features

Cetuximab may be beneficial beyond progression in certain patients with mCRC

Cetuximab may be beneficial beyond progression in certain patients with mCRC

Continuing second-line cetuximab beyond progression following first-line chemotherapy and an anti-EGFR monoclonal antibody is beneficial for quadruple wild-type metastatic colorectal cancer.

Study confirms benefit of regorafenib in previously treated metastatic colorectal cancer

Study confirms benefit of regorafenib in previously treated metastatic colorectal cancer

Researchers have confirmed that regorafenib is beneficial for the treatment of patients with previously treated metastatic colorectal cancer.

Fecal immunochemical testing may reduce colorectal cancer mortality

Fecal immunochemical testing may reduce colorectal cancer mortality

Fecal immunochemical testing screening for colorectal cancer demonstrated a significant reduction in mortality.

Special research update for 2014 presented for gastroenterology

Special research update for 2014 presented for gastroenterology

In the update, authors summarize 2014 studies that are highly relevant to gastroenterology, including esophageal diseases, pancreatic cancer, and colorectal cancer.

Patients with gastrointestinal tumors may have increased risk of developing other cancers

Patients with gastrointestinal tumors may have increased risk of developing other cancers

Patients with gastrointestinal stromal tumors (GIST) have a higher risk of developing additional malignancies before and after diagnosis.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs